A screening method developed by MIT researchers targets hydrogen peroxide in the search for new cancer therapeutics.

Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.

A new RNA-based control switch could be used to trigger production of therapeutic proteins to treat cancer or other diseases.

The method could be a route to quicker, less invasive cancer diagnoses.

A new study finds cutting off cells’ supplies of lipids can slow the growth of tumors in mice.

By combining chemotherapy, tumor injury, and immunotherapy, researchers show that the immune system can be re-engaged to destroy tumors in mice.

A new study shows a link between patient survival and changes in tumor cell mass after glioblastoma treatment.

MIT engineers devised a way to count elusive circulating tumor cells in mice, allowing them to study the dynamics of metastasis.

Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.

The researchers hope scientists and regulators will consider a broader class of compounds in evaluating cancer risk due to PAH exposure.